Stay updated on Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.

Latest updates to the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe footer’s ClinicalTrials.gov release label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check19 days agoChange DetectedA notice was added stating that NIH is transitioning to use “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.SummaryDifference0.5%

- Check26 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check33 days agoChange DetectedThe record history adds a newer update documenting a change to the study status, following the version submitted on 2026-09-30. This reflects a meaningful update to the trial’s operational status.SummaryDifference0.4%

- Check54 days agoChange DetectedThe study record history gains a new revision entry dated 2026-09-14 with Revision: v3.7.0. A related 2026-09-10 entry for Study Status appears, reflecting a maintenance update to the record.SummaryDifference0.4%

- Check76 days agoChange DetectedA new revision entry (v3.6.6) was added and the previous one (v3.6.5) removed in the record history, indicating a platform update to the page rather than a change to the study details.SummaryDifference0.1%

Stay in the know with updates to Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.